114美女做爰视频在线,乱子伦在线视频,国产成人免费视频网站视频社区

The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.

Continue Back

Search

【Company News】Gan & Lee CEO Du Kai and Brazilian Health Minister?Convene to Forge New Frontiers in Diabetes Prevention and Treatmen

【Company News】Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (OPTIMUM-1) of Bofanglutide (GZR18) Injection in Chinese Patients with Type 2 Diabetes Mellitus

【Company News】Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (SUPER-3) of Once-weekly Basal Insulin GZR4 Injection in Chinese Patients with Type 2 Diabetes Mellitus

【Company News】Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (SUPER-2) of Once-weekly Basal Insulin GZR4 injection in Chinese Patients with type 2 diabetes Mellitus

【Company News】Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (SUPER-1) of Once-weekly Basal Insulin GZR4 injection in Chinese Patients with Type 2 Diabetes Mellitus

【Company News】Gan & Lee Pharmaceuticals Announced First Participant Dosed in a Phase 3 Clinical Study (OPTIMUM-2) of Bofanglutide (GZR18) injection in Chinese Patients with Type 2 Diabetes Mellitus

【Company News】Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

【Company News】Gan & Lee Pharmaceuticals to Present Positive Data from Two Clinical Studies of GZR4, a Once-weekly Insulin, at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

【Company News】Gan & Lee Pharmaceuticals Successfully Shines at the American Diabetes Association's 84th Scientific Sessions

【Company News】Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions

【Company News】Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions

【Company News】Preview of Meeting | Gan & Lee Pharmaceuticals presents at American Diabetes Association’s 84th Scientific Sessions – A Convergence of Global Leaders in Diabetes Research and Care

【Company News】Gan & Lee Pharmaceuticals' Overseas Clinical Research on Insulin Glargine was Published in Journal Diabetes, Obesity and Metabolism

【Exhibitions】American Diabetes Association in San Diego, California

【Company News】Gan & Lee Pharmaceuticals' Overseas Clinical Research on Three Insulin Products was Published in Journal Diabetes, Obesity and Metabolism

Subscribe